Page 38 - Roadmap
P. 38

MOMENTUM OF INNOVATION







                                      7.3. HEALTH AND FOOD SCIENCES

             CLINICAL MEDICINE RESEARCH INFRASTRUCTURE GROUP, ECRIN-ERIC NETWORK


















        Presentation of the RI group
        The European Clinical Research Infrastructure Network (ECRIN ERIC) is a nonprofit organisation classified as “land-
        mark” in the ESFRI Roadmap, which aims to support scientific, multi-centre drug development research with no com-
        mercial intent in Europe. Through the HECRIN Consortium, Hungary became a full-fledged member in the
        ECRIN-ERIC in 2014. The HECRIN Consortium supports the internationalisation of clinical research initiated by
        Hungarian researchers and involves Hungary in the clinical research projects of other European countries. The results
        of human clinical trials have a significant impact on the development of clinical medicine.












        National coordinator of the RI group:                    Background information
        University of Pécs, Szentágothai Research Institute      The HECRIN Consortium operates as a distributed research in-
                                                                 frastructure. It represents 125 university clinics and diagnostic in-
        Contact: Gábor L. Kovács                                 stitutes, as well as 100 hospital units, and – apart from county
        Email: kovacs.l.gabor@pte.hu                             hospitals to be joining later – covers the entire Hungarian research
        Website: http://szkk.pte.hu/                             network capable of innovative clinical research. In 2017, the
        ECRIN contact point: Dr. Zita Tarjányi                   NRDI Office has officially announced Hungary’s participation in
        Email: tarjanyi.zita@pte.hu                              the ECRIN ERIC infrastructure. Hungary is represented by the
                                                                 NRDI Office, the HECRIN Consortium works as the Hungarian
        Partners: PTE Clinical Centre – multiple examination locations; UP   science centre, and the leader is the University of Pécs (based on
        Human Clinical Examination Registration Centre; DE Clinical Centre –   the decision of HECRIN Consortium members, and the approval
        multiple examination locations; DE Coordination Centre for Drug Deve-  of the State Secretariat for Health of the Ministry of Human Ca-
        lopment; SE Clinical Centre – multiple examination locations; SE Clinical   pacities and the NRDI Office). The HECRIN Consortium is pro-
        Centre, Registration Office; SZTE Clinical Centre – multiple examination   fessionally coordinated by Dr. Gábor L. Kovács (PTE), member
        locations; SZTE Clinical Centre, Clinical Research Coordination Office;   of the Hungarian Academy of Sciences.
        National Institute of Oncology; National Institute of Rheumatology and
        Physiotherapy; National Institute of Clinical Neurosciences; National    Aim of the RI group
        Korányi Institute for Pulmonology; Gottsegen György Hungarian Institute   Clinical trials are usually financed by European or national re-
        of Cardiology; State Hospital for Cardiology, Balatonfüred; Heim Pál   search funds or non-profit organisations. The HECRIN Consor-
        Children’s Hospital; MCRN Hungary (Medicines for Children Research   tium received government subsidy (GINOP-2.3.3-15; EFOP
        Network); MTA TTK Brain Imaging Centre                   3.6.2-16-2017-00009) for the development of the integrated, har-
                                                                 monised clinical trial network at the trial sites of the four Hun-
        ESFRI connection: ECRIN-ERIC                             garian universities. The goal is to accentuate Hungary’s capabilities
                                                                 in innovative, high-quality clinical research, including studies on
        Status of the RI group: under implementation             medicines, clinical nutrition science, pharmaceutical drugs and
                                                                 medical devices. The Consortium supports the strengthening of
                                                                 the research potential and its translation into practice through ac-
                                                                 credited processes, promotes continuous professional training, and
                                                                 makes efforts to exploit the wealth of clinical data in research.



                                                            38
   33   34   35   36   37   38   39   40   41   42   43